C
ClearPoint Neuro, Inc.
CLPT · NASDAQ · Healthcare · 460M
Closing price
$10.48
-0.10% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
10.6×
Enterprise value / EBITDAEV/EBITDA
-14.8×
Free cash flow yieldFCF yield
-8.2%
Return on equityROE
-91.1%
Operating margin
-65.4%
Net debt / EBITDAbalance-sheet strength
-0.6×
Interest coverage
-10.1×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.